RISK-FACTORS AND OUTCOME OF 107 PATIENTS WITH DECOMPENSATED LIVER-DISEASE AND ACUTE-RENAL-FAILURE (INCLUDING 26 PATIENTS WITH HEPATORENAL-SYNDROME) - THE ROLE OF HEMODIALYSIS

The prognosis of acute renal failure in patients with preexisting liver decompensation is poor and hemodialysis is considered futile, especially for hepatorenal syndrome (HRS). Since we observed a more favorable outcome in some patients, we retrospectively evaluated 107 patients with decompensated liver disease and acute renal failure (serum creatinine > 200 mu mol/L) treated at the medical department of a university hospital in a 10-year period (1980-1990). HRS in the strict sense (urine-Na < 20 mmol/L while on furosemide) was diagnosed in 26 of 107 patients (24%). Renal function remained compensated in 25 patients, while 82 patients fulfilled the criteria for dialysis treatment (creatinine > 500 mu mol/2 and/or diuresis < 500 mL/day). In contrast to the current doctrine, 38 of the 82 patients were given hemodialysis (46%). Using the Cox proportional hazard model, the relative risk (presence vs, absence of a risk factor) of dying was increased 8.2-foId (3.9-17.2) in patients with thrombocytopenia < 100/nL, 3.9-fold (1.4-11.3) in those with hepatic encephalopathy and prothrombin time < 30%, 2.8-fold (1.6-4.8) in patients with malignoma, and 2.7-fold (1.5-4.8) in patients not submitted to dialysis despite its indication. In the CART statistics (classification and regression tress), the 33 patients with the poorest outcome were characterized exclusively by thrombocytopenia < 100/nL. HRS in the strict sense was nor an independent risk factor The CART group of 43 patients with favorable prognosis (compensated renal failure or treatment by hemodialysis, absent malignancy) had a 1-year survival rate of 38%. We conclude that thrombocytopenia, encephalopathy and malignoma, bur not HRS per se, are fatal signs that make hemodialysis futile in patients with acute renal failure and decompensated liver disease.